Staphylococcus epidermidis Isolated in 1965 Are More Susceptible to Triclosan than Current Isolates

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Skovgaard, Sissel ^a,b   Nielsen, Lene Nørby ^b   Larsen, Marianne Halberg ^b   Skov, Robert Leo ^c   Ingmer, Hanne ^b   Westh, Henrik ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CEFOXITIN; MESSENGER RNA; PHENYLALANINE; TRICLOSAN; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; DRUG TOLERANCE; FABL GENE; GENE MUTATION; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SEQUENCE ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS; TRICLOSAN;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84876182475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062197     Document Type: Article

References (42)

1. Russell AD, (2002) Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 92Suppl: 121S-135S.
2. Escalada MG, Russell AD, Maillard JY, Ochs D, (2005) Triclosan-bacteria interactions: single or multiple target sites? Lett Appl Microbiol 41: 476-481.
3. Jones RD, Jampani HB, Newman JL, Lee AS, (2000) Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28: 184-196.
4. SCCS (Scientific committee on Consumer Safety) (2010) Opinion on triclosan (antimicrobial resistance). Available: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_023.pdf. Accessed 27 December 2012.
5. Dann AB, Hontela A, (2011) Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol 31: 285-311.
6. Tamura I, Kagota KI, Yasuda Y, Yoneda S, Morita J, et al. (2012) Ecotoxicity and screening level ecotoxicological risk assessment of five antimicrobial agents: triclosan, triclocarban, resorcinol, phenoxyethanol and p-thymol. J Appl Toxicol. DOI: 10.1002/jat.2771.
7. Aiello AE, Marshall B, Levy SB, la-Latta P, Larson E, (2004) Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 48: 2973-2979.
8. Cole EC, Addison RM, Rubino JR, Leese KE, Dulaney PD, et al. (2003) Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol 95: 664-676.
9. Sullivan A, Wretlind B, Nord CE, (2003) Will triclosan in toothpaste select for resistant oral streptococci? Clin Microbiol Infect 9: 306-309.
10. Jones CL, Ritchie JA, Marsh PD, Van der OF, (1988) The effect of long-term use of a dentifrice containing zinc citrate and a non-ionic agent on the oral flora. J Dent Res 67: 46-50.
11. Tkachenko O, Shepard J, Aris VM, Joy A, Bello A, et al. (2007) A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes. Res Microbiol 158: 651-658.
12. Sanchez P, Moreno E, Martinez JL, (2005) The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 49(2): 781-782.
13. Braoudaki M, Hilton AC, (2004) Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 42: 73-78.
14. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, et al. (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45: 428-432.
15. Rogers KL, Fey PD, Rupp ME, (2009) Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 23: 73-98.
16. Schmid MB, Kaplan N, (2004) Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 48: 1397-1399.
17. Heath RJ, Li J, Roland GE, Rock CO, (2000) Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem 275: 4654-4659.
18. Andrews JM, (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48Suppl 1: 5-16.
19. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Available: http://www.eucast.org/clinical_breakpoints/. Accessed 27 December 2012.
20. European Committee on Antimicrobial Susceptibility Testing. Antimicrobial susceptibility testing EUCAST disk diffusion method. Available: http://www.eucast.org/antimicrobial_susceptibility_testing/disk_diffusion_methodology/. Accessed 27 December 2012.
21. Bryson V, Szybalski W, (1952) Microbial Selection. Science 116: 45-51.
22. Multilocus sequence typing. Available: http://sepidermidis.mlst.net/. Accessed 27 December 2012.
23. Frees D, Chastanet A, Qazi S, Sorensen K, Hill P, et al. (2004) Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol Microbiol 54: 1445-1462.
24. Fan F, Yan K, Wallis NG, Reed S, Moore TD, et al. (2002) Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 46: 3343-3347.
25. Brenwald NP, Fraise AP, (2003) Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 55: 141-144.
26. Ciusa ML, Furi L, Knight D, Decorosi F, Fondi M, et al. (2012) A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. Int J Antimicrob Agents 40: 210-220.
27. Xu H, Sullivan TJ, Sekiguchi J, Kirikae T, Ojima I, et al. (2008) Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus. Biochemistry 47: 4228-4236.
28. Bayston R, Ashraf W, Smith T, (2007) Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 59: 848-853.
29. Seaman PF, Ochs D, Day MJ, (2007) Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 59: 43-50.
30. Slater-Radosti C, Van AG, Greenwood R, Nicholas R, Keller PM, et al. (2001) Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother 48: 1-6.
31. Suller MT, Russell AD, (2000) Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 46: 11-18.
32. Wootton M, Walsh TR, Davies EM, Howe RA, (2009) Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus. Infect Control Hosp Epidemiol 30: 226-232.
33. Saleh S, Haddadin RN, Baillie S, Collier PJ, (2011) Triclosan-an update. Lett Appl Microbiol 52: 87-95.
34. Russell AD, (2004) Whither triclosan? J Antimicrob Chemother 53: 693-695.
35. McMurry LM, Oethinger M, Levy SB, (1998) Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166: 305-309.
36. Massengo-Tiasse RP, Cronan JE, (2008) Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase. J Biol Chem 283: 1308-1316.
37. Massengo-Tiasse RP, Cronan JE, (2009) Diversity in enoyl-acyl carrier protein reductases. Cell Mol Life Sci 66: 1507-1517.
38. Heath RJ, Rock CO, (2000) A triclosan-resistant bacterial enzyme. Nature 406: 145-146.
39. Yazdankhah SP, Scheie AA, Hoiby EA, Lunestad BT, Heir E, et al. (2006) Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 12: 83-90.
40. Meade MJ, Waddell RL, Callahan TM, (2001) Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 204: 45-48.
41. Turtiainen J, Saimanen EI, Makinen KT, Nykanen AI, Venermo MA, et al. (2012) Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg 36: 2528-2534.
42. Aiello AE, Larson EL, Levy SB, (2007) Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 45Suppl 2: S137-S147.